Vimarsana
Biggest News Aggregation in the World

Rocket Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rocket Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rocket Pharma Today - Breaking & Trending Today

Regenxbio CEO to step down after 15 years - Vimarsana News

Regenxbio CEO to step down after 15 years

BioPharma

Rocket Pharma Seeks Gene Therapy Revolution For Genetic Heart Disease - Vimarsana News

Rocket Pharma Seeks Gene Therapy Revolution For Genetic Heart Disease

Rocket Pharma has a pipeline of six gene therapy programs addressing cardiovascular and hematology-based diseases at the genetic level.

Source: forbes.com
Lexeo's IPO Raises $100M for Gene Therapies That Treat the Heart, Protect the Brain - Vimarsana News

Lexeo's IPO Raises $100M for Gene Therapies That Treat the Heart, Protect the Brain

The gene therapy programs of Lexeo Therapeutics span rare forms of cardiomyopathy and certain types of Alzheimer’s disease. But Lexeo’s IPO comes as a rival gene therapy developer sues the biotech, claiming its work employs stolen trade secrets.

Rocket Pharmaceuticals Announces Presentations Highlighting Lentiviral and AAV Gene Therapies at the 30th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT) - Vimarsana News

Rocket Pharmaceuticals Announces Presentations Highlighting Lentiviral and AAV Gene Therapies at the 30th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)

Rocket Pharmaceuticals, Inc. , a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare disorders with high unmet need, today...

Ascidian Therapeutics Announces Three Key Development Team Appointments as It Advances Its Lead Program Toward the Clinic - Vimarsana News

Ascidian Therapeutics Announces Three Key Development Team Appointments as It Advances Its Lead Program Toward the Clinic

/PRNewswire/ -- Ascidian Therapeutics, a biotechnology company focused on treating human diseases by rewriting RNA, announced today three new appointments to...